Veritas In Silico Inc. (TYO:130A)
Japan · Delayed Price · Currency is JPY 436.00
+2.00 (0.46%)
Sep 16, 2026, 3:30 PM JST
Veritas In Silico Market Cap
Veritas In Silico has a market cap or net worth of 2.82 billion as of September 15, 2026. Its market cap has decreased by -37.55% in one year.
Market Cap
2.82B
Enterprise Value
1.39B
Revenue
84.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
436.00
ChartMarket Cap Chart
Since February 8, 2024, Veritas In Silico's market cap has decreased from 15.76B to 2.82B, a decrease of -82.14%. That is a compound annual growth rate of -48.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.82B | -9.58% |
| Dec 30, 2025 | 3.11B | -45.58% |
| Dec 30, 2024 | 5.72B | -63.69% |
| Feb 8, 2024 | 15.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.39B |
| Chordia Therapeutics | 5.33B |
| D. Western Therapeutics Institute | 5.01B |
| Ribomic | 4.52B |
| Transgenic Group | 4.33B |
| Kohjin Bio | 4.25B |
| Modalis Therapeutics | 3.76B |
| Kringle Pharma | 3.56B |